« previous next »
Pages: [1]   Go Down

Author Topic: New cancer drug shows encouraging results in Phase I/II trial  (Read 55 times)

Ketua Dobbs

  • Administrator
  • Rank: Jr. Consultant
  • *****
  • Posts: 699
  • Ketua
    • DOBBS
  • Field of Practice: CLINICAL HAEMATOLOGY
  • State: Selangor
New cancer drug shows encouraging results in Phase I/II trial
« on: September 16, 2024, 09:18:37 AM »
New cancer drug shows encouraging results in Phase I/II trial

The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced or metastatic solid tumors, according to interim data shared today at the 2024 European Society for Medical Oncology (ESMO) Congress by researchers from The University of Texas MD Anderson Cancer Center.
Source: New cancer drug shows encouraging results in Phase I/II trial
Logged
Let's make Bulletin Boards great again

Doctors Only Bulletin Board System (DOBBS)

New cancer drug shows encouraging results in Phase I/II trial
« on: September 16, 2024, 09:18:37 AM »
Pages: [1]   Go Up
« previous next »
 


Powered by EzPortal